![]() |
市場調查報告書
商品編碼
2044342
2034年農業生物製品市場預測-按產品類型、原料、作物類型、功能、配方、最終用戶細分市場和地區分類的全球分析Agri-Biologicals Market Forecasts to 2034 - Global Analysis By Product Type (Biopesticides, Biofertilizers, Biostimulants and Macro-organisms), Source, Crop Type, Function, Formulation, Mode of End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球農業生物產品市場規模將達到 182 億美元,並在預測期內以 12.3% 的複合年成長率成長,到 2034 年將達到 461 億美元。
農業生物製品是指一大類天然來源的農業材料,包括生物農藥、生物肥料、生物促效劑、生物體及其代謝物製成的大型生物。這些產品透過生物機製而非合成化學物質來提高作物產量、防治病蟲害並改善土壤健康。這些產品包括源自細菌和真菌的生物殺蟲劑、具有固氮和溶磷特性的生物肥料接種劑、源自海藻和腐植酸的生物促效劑、有益線蟲和捕食性昆蟲,以及蛋白質水解物氨基酸製劑。它們支持全球傳統和有機農業系統中的綜合蟲害管理(IPM)和永續集約化農業實踐。
加強農藥監管
歐盟的「從農場到餐桌」舉措、美國環保署(EPA)的活性成分重新評估計畫以及主要農業市場的國家農藥減量指令,正在加速合成化學農藥的解除管制。這催生了對生物作物保護替代品的結構性需求,因為生物產品比合成化學品更容易通過監管核准流程。從歐盟到2030年將化學農藥使用量減少50%的目標,要求歐洲作物保護市場轉向生物材料,從而在歐洲商業農業系統中產生對經證實有效的生物農藥和生物促效劑產品的龐大且可預測的機構需求。
與績效一致性相關的挑戰
農業生物製品在商業性田間應用的有效性往往比合成化學藥劑波動更大。這是因為活微生物和生物化合物對極端溫度、紫外線照射和土壤pH值波動非常敏感,而且它們與常用農藥的不相容性限制了其保存期限和田間表現的穩定性。生物材料在農業領域的應用受到其在不當儲存和施用條件下性能差異的限制,而傳統化學農藥則能有效避免這些問題。因此,必須增加對農業技術支援的投入,以確保不同作物種植和氣候環境下的使用者能夠採用並持續使用商業生物材料。
碳農業中的生物整合
不斷擴大的排碳權計畫要求,強制改善土壤健康並減少對合成材料的依賴,為農民採用生物肥料和生物促效劑提供了持續的獎勵,這些措施被視為符合碳排放結算計劃的、經過檢驗的再生農業實踐。要求提供減少合成氮肥用量證明的農業碳計劃,為採用固氮生物肥料接種劑提供了直接的經濟獎勵,生物來源材料公司可以利用這些激勵作為補充收入來源,支持農民的轉型經濟。將農業生物材料的使用數據整合到數位碳監測平台中,可以從實施生物管理的田地中創建檢驗的碳固定信用額度。
合成化學產品的成本優勢
在玉米、小麥和大豆等主要經濟作物中,與生物農藥相比,現有的合成化學農藥和化肥仍具有顯著的單位面積成本效益。在這些市場中,除非生物農藥能夠證明其產量保護效果相當,否則大宗商品價格壓力限制了農民為生物農藥支付溢價的意願。通用合成化學品生產商由於產能低、分銷網路成熟,持續製造價格競爭壓力,限制了生物農藥在價格敏感的傳統經濟作物市場中的滲透,因為在這些市場中,化學農藥已深深融入生產體系。
疫情擾亂了農藥供應鏈,凸顯了生產商對進口合成活性成分的依賴,並加速了監管機構和市場對國產生物替代品的關注。在一些地區,由於疫情導致的勞動力短缺,農藥使用量減少,這為早期採用包含生物防治的綜合蟲害管理(IPM)方案奠定了基礎。疫情後,各國政府加大對糧食安全和再生農業項目的投入,加快了農業生物製品的註冊支持和農業工人培訓計劃,為這些產品在主要農業市場的商業性化應用奠定了基礎。
在預測期內,大型生物製品領域預計將佔據最大的市場佔有率。
預計在預測期內,宏觀生物防治領域將佔據最大的市場佔有率。這主要歸功於有益昆蟲和昆蟲病原線蟲在蔬菜、桃子和觀賞植物等高價值特種作物生物防治的廣泛商業性應用。在這些作物中,高價策略支撐了生物投入品的經濟效益。商業溫室和保護性農場經營者實施的捕食性蟎蟲和寄生蜂防治方案已展現出顯著成效,從而帶動了對宏觀生物防治產品的強勁復購需求。此外,特種園藝產業為實現高階零售通路的零殘留生產所做的努力,也支撐了宏觀生物防治解決方案的高價位。
在預測期內,微生物領域預計將呈現最高的複合年成長率。
在預測期內,微生物領域預計將呈現最高的成長率。這主要得益於新型微生物菌株的快速開發和商業化,這些菌株已被證實對玉米、大豆和小麥等種植面積廣闊的通用作物具有顯著的防治效果。這些作物的種植面積遠大於目前主要採用大型生物進行生物防治的特殊作物。微生物發酵技術的進步、菌株穩定性的提高以及種子處理配方的開發,使得細菌生物促效劑和生物農藥能夠可靠地應用於大面積農田。BASF、拜耳和科迪華等領先的農藥生產商正在將其微生物產品系列商業化,以滿足市場對生物差異化作物投入品的需求。
在預測期內,北美地區預計將保持最大的市場佔有率。這主要得益於全球最大的商業農業部門、加州高價值特種作物的生產、中西部地區大田作物中生物促效劑的廣泛應用,以及最成熟的生物農藥法律規範,這些都為新產品的快速商業化提供了支持。美國擁有最集中的農業生物技術創新公司和風險投資,這些公司和投資正支持下一代微生物產品的開發。零售雜貨店對永續採購的承諾正在推動北美園藝供應鏈中生物材料的應用。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸功於印度和中國政府主導的大規模有機農業轉型計劃、限制合成農藥使用的日益嚴格的環境法規,以及熱帶水果、蔬菜和水稻生產部門的巨大規模——在這些部門,生物農藥替代品正迅速獲得商業性支持。在印度,一項旨在推廣「零預算自然農業」的國家計劃,惠及數千萬小規模農戶,正在推動生物肥料和生物農藥的大規模應用。在中國,針對主要糧食和蔬菜生產部門的農藥減量指令,正在系統性地催生對已通過核准的生物農藥替代品的需求。
According to Stratistics MRC, the Global Agri-Biologicals Market is accounted for $18.2 billion in 2026 and is expected to reach $46.1 billion by 2034 growing at a CAGR of 12.3% during the forecast period. Agri-biologicals refer to a broad category of naturally derived agricultural input products including microbial biopesticides, biofertilizers, biostimulants, and macro-organisms produced from living organisms or their metabolites that enhance crop productivity, protect against pests and diseases, and improve soil health through biological rather than synthetic chemical mechanisms. These products encompass bacterial and fungal bioinsecticides, nitrogen-fixing and phosphate-solubilizing biofertilizer inoculants, seaweed and humic acid biostimulants, beneficial nematodes and predatory insects, and protein hydrolysate amino acid formulations that support integrated pest management and sustainable intensification practices in conventional and organic cropping systems globally.
Regulatory pesticide restrictions
Accelerating regulatory withdrawal of synthetic chemical pesticides under EU Farm-to-Fork initiatives, US EPA active ingredient re-evaluation programs, and national pesticide reduction mandates across major agricultural markets is creating structural replacement demand for biological crop protection alternatives with regulatory approval pathways that biological products navigate more readily than synthetic chemicals. The EU's objective of reducing chemical pesticide use by 50 percent by 2030 is creating a mandatory transition to biological inputs across European crop protection markets, generating great and predictable institutional demand for biopesticide and biostimulant products with documented efficacy across European commercial cropping systems.
Performance consistency challenges
Agri-biological product efficacy in commercial field applications is significantly more variable than synthetic chemical inputs due to the sensitivity of living microbial organisms and biological compounds to temperature extremes, UV exposure, soil pH variation, and incompatibility with commonly co-applied agrochemicals that limit shelf life and field performance consistency. Farmer adoption of biological inputs is constrained by documented performance inconsistency under sub-optimal storage and application conditions that conventional chemical crop protection products reliably avoid, requiring substantial agronomic support investment to ensure successful adoption and retention of commercial biological input users across diverse cropping and climatic environments.
Carbon farming biological integration
Growing carbon credit program requirements mandating soil health improvement and reduced synthetic input dependency are creating aligned incentives for farmer adoption of biofertilizers and biostimulants as verified regenerative agricultural practices eligible for carbon payment schemes. Agricultural carbon programs requiring documented reductions in synthetic nitrogen fertilizer application provide direct financial incentives for adoption of nitrogen-fixing biofertilizer inoculants that biological input companies can leverage as complementary revenue streams supporting farmer transition economics. Integration of agri-biological adoption data into digital carbon monitoring platforms is enabling verified carbon sequestration credit generation from biologically managed fields.
Synthetic chemistry cost advantage
Established synthetic chemical pesticides and fertilizers maintain significant cost-per-hectare efficacy advantages over agri-biological alternatives across major commodity crops, including corn, wheat, and soybean, where commodity price pressure limits farmer willingness to pay premiums for biological inputs without demonstrated equivalent yield protection outcomes. Generic synthetic chemistry manufacturers maintaining low-cost production capacity and established distribution networks create sustained competitive pricing pressure that limits biological input market penetration in price-sensitive conventional commodity farming markets where chemical inputs are deeply embedded in production systems.
The pandemic disrupted agricultural chemical supply chains and highlighted grower dependence on imported synthetic active ingredients, accelerating regulatory and commercial interest in domestically producible biological alternatives. Reduced pesticide application during pandemic-related labor shortages in some regions provided early adoption evidence for IPM programs integrating biological controls. Post-pandemic, government food security investments and regenerative agriculture program funding have accelerated agri-biological product registration support and farmer education programs that are building commercial adoption infrastructure across key agricultural markets.
The macro-organisms segment is expected to be the largest during the forecast period
The macro-organisms segment is expected to account for the largest market share during the forecast period, due to the widespread commercial adoption of beneficial insects and entomopathogenic nematodes for biological pest control in high-value specialty crops including vegetables, soft fruits, and ornamentals, where premium pricing supports biological input economics. Commercial greenhouse and protected cultivation operators deploying predatory mite and parasitic wasp programs have demonstrated reliable efficacy outcomes that create strong reorder demand for macro-biological pest control products. The specialty horticulture sector's commitment to residue-free production for premium retail channels is supporting sustained premium pricing for macro-organism biological control solutions.
The microbials segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbials segment is predicted to witness the highest growth rate, driven by rapid development and commercialization of novel microbial strains with demonstrated efficacy across broad-acre commodity crop applications in corn, soybean, and wheat that represent vastly larger addressable acreage than the specialty crops currently dominated by macro-organism biological controls. Advances in microbial fermentation technology, strain stability improvement, and seed treatment formulation are enabling reliable broad-acre deployment of bacterial biostimulants and biopesticide products. Major agrochemical companies, including BASF, Bayer, and Corteva, are commercializing microbial portfolios to capture biologically differentiated crop input demand.
During the forecast period, the North America region is expected to hold the largest market share, due to the world's largest commercial agricultural sector with high-value specialty crop production in California, advanced biostimulant adoption in row crop production across the Midwest, and the most mature biological crop protection regulatory framework supporting rapid new product commercialization. The United States hosts the largest concentration of agri-biological innovation companies and venture investment supporting next-generation microbial product development. Retail grocery sustainability sourcing commitments are driving the adoption of biological inputs across North American horticultural supply chains.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to large-scale government organic farming conversion programs in India and China, growing environmental regulations restricting synthetic pesticide applications, and the massive scale of tropical fruit, vegetable, and rice production sectors where biological alternatives to synthetic pesticides are gaining rapid commercial traction. India's national program promoting zero-budget natural farming across tens of millions of smallholder farmers is driving large-scale biofertilizer and biopesticide adoption. China's pesticide reduction mandate covering major grain and vegetable producing provinces is creating systematic demand for approved biological crop protection substitutes.
Key players in the market
Some of the key players in Agri-Biologicals Market include BASF SE, Bayer AG, Corteva Agriscience, Syngenta AG, UPL Limited, FMC Corporation, Novozymes A/S, Lallemand Inc., Marrone Bio Innovations, Valent BioSciences LLC, Koppert Biological Systems, Certis USA LLC, Rizobacter Argentina S.A., Vegalab S.A., Isagro S.p.A., Biolchim S.p.A., Andermatt Biocontrol AG, and Sipcam Oxon S.p.A..
In April 2026, Corteva Agriscience LLC introduced a next-generation biostimulant product combining microbial and biochemical actives to improve nutrient uptake efficiency and drought tolerance across major commodity grain crops globally.
In February 2026, Novozymes A/S announced a strategic partnership with a major grain seed company to integrate nitrogen-fixing biofertilizer inoculants into commercial corn and soybean seed treatment programs for broad-acre markets.
In January 2026, Koppert Biological Systems expanded production capacity for beneficial insect macro-organism products to meet growing demand from protected cultivation operators transitioning to fully chemical-free biological pest management programs.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.